Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Drug Discovery and Development: Page 2
Illumina Accelerator announces new genomics startups
By
LabPulse.com staff writers
Of the seven companies, three will mark the inaugural funding cycle of Illumina Accelerator Cambridge, U.K., while four other firms will join as part of the eleventh funding cycle in the San Francisco Bay Area, according to Illumina.
June 22, 2020
Twist Bioscience, Sophia Genetics partner on NGS, DNA analysis
By
LabPulse.com staff writers
South San Francisco, CA-based Twist has developed a DNA synthesis platform that involves manufacturing synthetic DNA for use in NGS preparation and the development of antibody libraries that inform drug discovery. Sophia Genetics, which has offices in the U.S., Switzerland, and France, has developed an AI-powered platform for DNA analysis.
February 25, 2020
Fusion Genomics secures $1M U.S. to study respiratory infections panel
By
LabPulse.com staff writers
The Consortium Québécois sur la Découverte du Medicament (CQDM) is a Montreal-based biomedical research consortium that funds new technologies with potential value in facilitating drug discovery and development. The organization noted that since it was founded in 2008, it has raised more than $118 million Canadian ($90 million U.S.) through Canadian government programs and a wide range of pharmaceutical industry partners, including Merck, Pfizer, AstraZeneca, and Eli Lilly.
January 9, 2020
MilliporeSigma licenses CRISPR tech to Promega
By
LabPulse.com staff writers
Promega will use MilliporeSigma's CRISPR genome-editing technology to create research products and services, including those for drug development.
December 19, 2019
Amgen enlists Adaptive's clonoSeq in broad blood cancer deal
By
LabPulse.com staff writers
MRD-negativity is an increasingly important marker of treatment response in cancer drug development. Per the deal, Adaptive will provide MRD testing and analysis to inform Amgen's drug development and receive annual development fees, sequencing payments, and milestone payments.
September 18, 2019
Beckman Coulter buys acoustic liquid handling firm Labcyte
By
LabPulse.com staff writers
Labcyte is known for Echo, an acoustic droplet ejection technology that uses sound waves to transfer minute amounts of liquid with speed and accuracy. Incorporated into the company's Echo Liquid Handlers line of products, the technology enables more efficient lab workflow for applications such as drug discovery and genomics.
January 30, 2019
Previous Page
Page 2 of 2